BioSpace News Archive

Spinal cord stimulation devices are effective way of pain relief technique, which works through passing a low voltage electric current to the spinal cord.

Consequent upon tremendous expansion of gamma detection probe technology for the surgical management of numerous malignancies, the use of gamma probe device continues to rise.

The demand within the global D-dimer testing market is expected to rise alongside advancements in medical research and analysis.

Kaltech Co., Ltd., headquartered in Chuo-ku, Osaka, has announced that an experiment to test for 20 minutes the efficacy of a disinfectant deodorizer equipped with the company’s proprietary photocatalytic technology against airborne novel coronavirus in a fixed space confirmed an infectivity suppression effect.

Strong participation from international syndicate of investors, including Gilde Healthcare, Invus and BioMed Partners

International medical imaging IT and cybersecurity company Sectra has been selected by Jessa Hospital in Belgium to deliver its software solution for enterprise imaging.

Engitix Ltd, a biotechnology company with a portfolio of programmes in fibrosis and solid tumours and two significant partnerships based upon its proprietary human extracellular matrix platform, announced the appointment of Eduardo Bravo as Chairman of its Board of Directors.

Biofidelity Ltd, the cancer diagnostics company, announced the opening of its new headquarters as it continues its significant recruitment ahead of commercialization of its first products.

ERS Genomics Limited and Vivlion GmbH announced a non-exclusive license agreement granting Vivlion® access to ERS Genomics’ CRISPR/Cas9 patent portfolio, to enhance Vivlion’s gene editing reagents and screening services.

Viseon, Inc., a leader in minimally invasive spine surgery visualization technologies, announced MaxView™ facilitates more rapid adoption of Minimally Invasive Spine Surgery procedures by providing an enhanced teaching and learning experience.